Pulmonx LUNG
NASDAQ LUNG
$1.86 +0.02 (+1.37%)
As of: Oct 22, 2026 · 12:26 PM EDT

Pulmonx (LUNG) Liabilities and Shareholders Equity (2019 - 2025)

Updated

Pulmonx's Liabilities and Shareholders Equity was $129.29 million in Q4 2025, down 20.6% from $162.85 million a year earlier and down 6.5% from the prior quarter.

Analysis

Pulmonx (LUNG) Liabilities and Shareholders Equity (2019 - 2025) Analysis & Trends

From Q4 2019 onward, Pulmonx has reported Liabilities and Shareholders Equity for 23 quarters.

  • Liabilities and Shareholders Equity has now declined for five consecutive years, with a five-year compound annual growth rate of -13.3% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $162.85 million in FY2024 (-8.4%), $177.78 million in FY2023 (-8.2%), $193.68 million in FY2022 (-17.6%) and $235.17 million in FY2021 (-10.8%).
  • The Q4 2025 figure marks the lowest quarterly Liabilities and Shareholders Equity since Q3 2020.
  • Compared with a year earlier, Liabilities and Shareholders Equity has declined for 17 straight quarters, with an average decline of 13.5% over the last eight quarters.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q3 2021 (growth of 246.4%); the worst was Q4 2025 (a decline of 20.6%).
  • Per Business Quant data, LUNG's Liabilities and Shareholders Equity in the three quarters before Q4 2025 was $138.28 million (Q3 2025), $147.19 million (Q2 2025) and $150.74 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Thermo Fisher Scientific 253.84 Bn 232.87 Bn 4.88 Bn 113.17 Bn
2 Abbott Laboratories 177.90 Bn 148.33 Bn 7.27 Bn 109.22 Bn
3 Danaher 163.51 Bn 147.32 Bn 3.61 Bn 92.37 Bn
4 Intuitive Surgical 155.70 Bn 135.12 Bn 1.96 Bn 20.88 Bn
5 Medtronic 122.67 Bn 87.92 Bn 6.34 Bn 93.31 Bn
6 Stryker 118.12 Bn 104.23 Bn 4.50 Bn 47.93 Bn
7 Boston Scientific 67.11 Bn 61.88 Bn 3.85 Bn 45.22 Bn
8 Becton Dickinson 54.66 Bn 51.81 Bn 2.32 Bn 50.73 Bn
9 Edwards Lifesciences 51.62 Bn 35.63 Bn 1.35 Bn 13.87 Bn
10 Pulmonx 75.94 Mn -243.29 Mn - 129.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 129.29 Mn
Sep 30, 2025 138.28 Mn
Jun 30, 2025 147.19 Mn
Mar 31, 2025 150.74 Mn
Dec 31, 2024 162.85 Mn
Sep 30, 2024 167.40 Mn
Jun 30, 2024 172.63 Mn
Mar 31, 2024 164.58 Mn
Dec 31, 2023 177.78 Mn
Sep 30, 2023 185.02 Mn
Jun 30, 2023 193.11 Mn
Mar 31, 2023 201.27 Mn
Dec 31, 2022 193.68 Mn
Sep 30, 2022 202.20 Mn
Jun 30, 2022 212.73 Mn
Mar 31, 2022 222.85 Mn
Dec 31, 2021 235.17 Mn
Sep 30, 2021 246.82 Mn
Jun 30, 2021 248.94 Mn
Mar 31, 2021 255.27 Mn
API Access

Pulmonx Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LUNG&period=max&api_key=YOUR_API_KEY